http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009137946-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D515-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
filingDate | 2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2009137946-A |
titleOfInvention | Pyridazinone derivatives for use as glucansynthase inhibitors |
abstract | 1. The compound of formula I! ! or a pharmaceutically acceptable salt, solvate, ester or prodrug thereof, where! represents a double bond or a single bond in accordance with the requirements of valency, provided that when E represents N, a double bond is present, and R6 is absent; ! A represents O or S; ! D and E independently represent C or N,! with the proviso that when D is carbon, D is substituted with hydrogen, alkyl, an —Oalkyl, —Nalkyl or —Salkyl group; ! R3 is a moiety selected from the group consisting of alkyl, alkenyl, aryl, arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cyclenes, tsiklenilalkila, tsiklenilalkenila, heterocyclyl, heterocyclylalkyl, geterotsiklilalkenila, heterocyclenyl, geterotsiklenilalkila, geterotsiklenilalkenila , arylalkoxylalkyl, arylalkoxylalkenyl, cycloalkoxylalkyl, cycloalkoxylalkenyl, cycloalkenoxylalkyl and cycloalkenyloxyalkenyl,! wherein each of said alkyl, alkenyl, aryl, arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cyclenes, tsiklenilalkila, tsiklenilalkenila, heterocyclyl, heterocyclylalkyl, geterotsiklilalkenila, heterocyclenyl, geterotsiklenilalkila, geterotsiklenilalkenila, arilalkoksilalkila, arilalkoksilalkenila, tsikloalkoksilalkila, cycloalkoxylalkenyl, cycloalkenoxylalkyl, cycloalkenyloxyalkenyl may be unsubstituted or substituted with one or more moieties ntami, which may be identical or different, each Fra |
priorityDate | 2007-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 349.